Company Presentation
STALICLA SA
| Country: | Switzerland |
| Category: | Clinical Biotech Company |
| Room: | Rio |
| Date: | 25.04.2023 |
| Time: | 12:30 – 12:45 |
| Website: | https://stalicla.com |
| Speaker: | Lynn Durham, CEO & Founder |
Company profile
STALICLA is a clinical stage, precision molecular neuroscience biotech company with a mature pipeline for patients with Neurodevelopmental Disorders (NDDs) and Neuropsychiatric disorders. STALICLA´s unique approach addresses a principal weakness in the drug development process for NDDs and neuropsychiatric disorders: behavior is a terrible biomarker. STALICLA is currently preparing its next stage of growth, to advance its pipelines and to scale its platform.
